Bayer reported €4.32B in Cash and Equivalent for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Akzo Nobel AKZA:NA € 1087M 129M
Alcon AG ALC:SW 1.57B 199M
Amarin AMRN:US $ 222.88M 104.14M
Arkema AKE:FP € 2286M 129M
AstraZeneca AZN:LN 7067M 8500M
BASF BAS:GR € 2899M 30M
Bayer BAYN:GR € 4316M 927M
Corteva Inc CTVA:US $ 2.78B 82M
Covestro 1COV:GR 496M 360M
DSM DSM:NA € 871M 815M
Fresenius FRE:GR € 2413M 163M
Fresenius Medical Care FME:GR € 1562M 154.04M
Genmab GEN:DC DK 8729M 748M
Givaudan GIVN:VX 306M 105M
GlaxoSmithKline GSK:LN 3453M 50M
GRIFOLS GRF:SM € 397.86M 16.88M
Hikma Pharmaceutical HIK:LN 2M 321M
Johnson Matthey JMAT:LN 746M 165M
Linde LIN:GR € 4700M 1563M
Lonza Group LONN:SW 501M 6M
Merck MRK:GR € 1523M 302M
Novartis NOVN:VX SF 7211M 2094M
Philips PHIA:NA € 3827M 2824M
Ppg Industries PPG:US $ 1216M 21M
SAP SAP:GR € 7943M 179M
Solvay SOLB:BB € 1404M 188M
Umicore UMI:BB 1.19B 178.59M